rTMS in Spasmodic Dysphonia

Status Completed

Clinical Trial Summary

Focal dystonia is a neurological movement disorder characterized by excessive involuntary muscle contractions of any body part. Spasmodic dysphonia (SD) is a type of focal dystonia characterized by excessive contraction of intrinsic muscles in the larynx, leading to difficulty in speaking and affecting effective communication. The cause of SD is unknown and there are no treatments that produce long-term benefits. Previous studies have suggested that SD and other focal dystonias are associated with decreased inhibition in sensorimotor areas in the brain. However, no studies have investigated the effects of modulating excitability of the laryngeal motor cortex in healthy individuals or SD. The goal of this pilot project is to determine if brain excitability of the laryngeal motor cortex can be changed with low-frequency inhibitory repetitive transcranial magnetic stimulation (rTMS) in individuals with SD and healthy controls. Considering that rTMS at low frequencies (≤1 Hz) produces lasting inhibition in the brain, and that SD is associated with decreased cortical inhibition, the purpose of this pilot study is to determine safety, feasibility and response to 1Hz rTMS to the laryngeal motor cortex in individuals with SD and healthy people. The results will help understand changes associated with the disorder, as well as contribute to the development of future clinical interventions for SD.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02957942
Study type	Interventional
Source	University of Minnesota
Contact
Status	Completed
Phase	N/A
Start date	January 2017
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06111027` - Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia	Phase 1/Phase 2
Withdrawn	`NCT02061943` - Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change	N/A
Recruiting	`NCT05158166` - DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia	Phase 1/Phase 2
Recruiting	`NCT05580302` - Cortical Silent Period in Laryngeal Dystonia
Recruiting	`NCT05150106` - Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
Recruiting	`NCT05216770` - Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor	Early Phase 1
Recruiting	`NCT05150093` - Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor	N/A
Completed	`NCT00713414` - Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
Completed	`NCT01961297` - Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response	Phase 2
Completed	`NCT00118586` - Neuropathology of Spasmodic Dysphonia
Not yet recruiting	`NCT04938154` - A Phase 2 Trial of Deep Brain Stimulation for Spasmodic Dysphonia	Phase 2
Active, not recruiting	`NCT03292458` - Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor	Phase 2/Phase 3
Completed	`NCT02558634` - Thalamic Deep Brain Stimulation for Spasmodic Dysphonia- DEBUSSY Trial	N/A
Terminated	`NCT00895063` - Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia	N/A
Completed	`NCT05158179` - Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia	N/A
Not yet recruiting	`NCT06078527` - Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort	N/A
Enrolling by invitation	`NCT05892770` - Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia	Phase 1/Phase 2
Completed	`NCT04648891` - Spasmodic Dysphonia Pain	Phase 2/Phase 3
Completed	`NCT03042962` - Brain Networks in Dystonia
Completed	`NCT03746509` - Laryngeal Vibration for Spasmodic Dysphonia	N/A